These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 25090984)

  • 1. Supramolecular Nanomedicine - An Overview.
    Sekhon BS
    Curr Drug Targets; 2015; 16(13):1407-28. PubMed ID: 25090984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors.
    Domingues C; Alvarez-Lorenzo C; Concheiro A; Veiga F; Figueiras A
    Mol Pharm; 2019 Dec; 16(12):4757-4774. PubMed ID: 31633939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
    Cabral H; Nishiyama N; Kataoka K
    Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging.
    Li Y; Li Y; Zhang X; Xu X; Zhang Z; Hu C; He Y; Gu Z
    Theranostics; 2016; 6(9):1293-305. PubMed ID: 27375780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
    Zhai J; Fong C; Tran N; Drummond CJ
    ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What nanomedicine in the clinic right now really forms nanoparticles?
    Svenson S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticles: the future of nanomedicine.
    Banik BL; Fattahi P; Brown JL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):271-99. PubMed ID: 26314803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
    Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
    Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyester micelles for drug delivery and cancer theranostics: Current achievements, progresses and future perspectives.
    Yi Y; Lin G; Chen S; Liu J; Zhang H; Mi P
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():218-232. PubMed ID: 29208282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric mixed micelles as nanomedicines: Achievements and perspectives.
    Cagel M; Tesan FC; Bernabeu E; Salgueiro MJ; Zubillaga MB; Moretton MA; Chiappetta DA
    Eur J Pharm Biopharm; 2017 Apr; 113():211-228. PubMed ID: 28087380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Developments of Supramolecular Metal-based Structures for Applications in Cancer Therapy and Imaging.
    Pöthig A; Casini A
    Theranostics; 2019; 9(11):3150-3169. PubMed ID: 31244947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Supramolecular Agents for Theranostics].
    Deyev SM; Lebedenko EN
    Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.